jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

Aug. 08, 2024

Jan. 31, 2025

jRCT1050240107

Vertebral Augmentation versus Posterior Spinal Fusion for Severe Osteoporotic Vertebral Fractures: A Multicenter Randomized Controlled Trial (VERSUS study)

Vertebral Augmentation versus Posterior Spinal Fusion for Severe Osteoporotic Vertebral Fractures: A Multicenter Randomized Controlled Trial (VERSUS study)

Takahashi Shinji

Osaka Metropolitan University Graduate School of Medicine, Department of Orthopaedic Surgery

1-4-3, Asahimachi, Abeno-ku, Osaka, 545-8585, Osaka, Japan

+81-6-6645-3851

stakahashi@omu.ac.jp

Takahashi Shinji

Osaka Metropolitan University Graduate School of Medicine, Department of Orthopaedic Surgery

1-4-3, Asahimachi, Abeno-ku, Osaka, 545-8585, Osaka, Japan

+81-6-6645-3851

stakahashi@omu.ac.jp

Recruiting

Aug. 08, 2024

Sept. 11, 2024
90

Interventional

randomized controlled trial

open(masking not used)

no treatment control/standard of care control

parallel assignment

treatment purpose

1. Patients diagnosed with osteoporotic vertebral fractures (OVF) using X-ray, MRI, or CT from the date of jRCT registration until March 2028.
2. Patients with OVF who visited Osaka Metropolitan University Hospital or participating institutions.
3. Patients aged 65 or older at the time of consent.
4. Patients with fresh OVF within 2 months of injury.
5. Patients with severe low back pain (VAS >= 40).
6. Patients with OVF between T10 and L2 levels.
7. Patients who have poor prognostic factors with conservative treatment (e.g., cases with confined high signal intensity areas or diffused low signal intensity areas in the fractured vertebra on T2-weighted MR images, or cases with endplate injury on both sides).
8. Patients with severe mobility of the fractured vertebra (vertebral motion angle >= 14 degrees) or patients with endplate injury on both sides.

1. Patients who injured by high-energy trauma.
2. Patients with OVF unsuitable for vertebroplasty, such as those with diffuse idiopathic skeletal hyperostosis or ankylosing spondylitis.
3. Patients with stable OVF (vertebral motion angle < 14 degrees) or without endplate injury on both sides, for whom posterior fusion surgery is not indicated.
4. Patients with neurological deficits due to OVF.
5. Patients suspected of pathological fractures (e.g., OVF due to metastatic spinal tumors or pyogenic spondylitis).
6. Patients diagnosed with dementia.
7. Patients treated for psychiatric disorders, including those with strong psychosocial factors.
8. Patients treated for neurological disorders such as Parkinson's disease.
9. Patients seemed unsuitable for participation in the study by the primary physicians.

65age old over
No limit

Both

Osteoporotic Vertebral Fractures

Patients with severe osteoporotic vertebral fractures are randomly allocated to vertebroplasty and posterior spinal fusion.

Osteoporotic Vertebral Fracture, Osteoporosis, Vertebral Fracture

Randomized Controlled Trial, Vertebroplasty, Posterior Spinal Fusion

D016103

C000599360

Oswestry Dissability Index (ODI) 24 weeks after surgery

Incidence of complications, Spinal alignment, Clinical outcomes such as EQ5D-5L, visual analog scale and surgical satisfaction

none
Osaka Metropolitan University Hospital Certified Review Board
1-2-7, Asahimachi, Abeno-ku, Osaka, Osaka

+81-6-6645-3456

gr-a-knky-crb@omu.ac.jp
Approval

Aug. 02, 2024

No

none

History of Changes

No Publication date
2 Jan. 31, 2025 (this page) Changes
1 Aug. 08, 2024 Detail